Navigation Links
Project Achilles pinpoints vulnerabilities in ovarian cancer
Date:7/11/2011

Cancer is not invincible but its weaknesses can be difficult to detect. An effort known as Project Achilles named after the Greek warrior whose one vulnerability led to his undoing was launched to develop a systematic way of pinpointing these weak spots. In their largest and most comprehensive effort to date, researchers from the Broad Institute of MIT and Harvard and the Dana-Farber Cancer Institute examined cells from over 100 tumors, including 25 ovarian cancer tumors, to unearth the genes upon which cancers depend. One of these genes, PAX8, is altered in a significant fraction of ovarian tumors nearly one-fifth of those surveyed in the study. Their results appear online July 11 in Proceedings of the National Academy of Sciences.

"In this project, we're looking for all of the Achilles' heels of cancer. That is to say, we're looking for any instance where you inactivate a gene and affect the survival of cancer cells," said William Hahn, a senior associate member of the Broad and an associate professor at Dana-Farber and Harvard Medical School. The researchers silenced or suppressed thousands of genes using short hairpin RNAs (shRNAs), which offer a way to predict the effect of a drug or therapy that targets individual genes.

Recently, researchers involved in another major cancer project, The Cancer Genome Atlas (TCGA), reported that 1,800 genes in the ovarian cancer genome are repeatedly amplified, or present in extra copies. The Project Achilles team silenced more than 10,000 genes in its search for those that are needed for cancer cells to grow and survive. By harnessing the TCGA data, the researchers could rapidly pinpoint which of these 1,800 genes are essential to ovarian tumor growth.

Hahn describes the convergence of these two projects at the Broad Institute as representing a fundamental change in cancer research. "Not only can we characterize what genes are mutated or altered, but we can also simultaneously assess which of those are important functionally," he said.

The team used a pool of more than 54,000 shRNAs from the library developed by the Broad's RNAi Platform. "The methods that we have developed in the RNAi Platform make it practical and relatively inexpensive to screen shRNAs at a genomic scale and our first area of application was in cancer research," said David Root, director of the RNAi Platform. "The scale-up to the 100 cell lines reported in this most recent paper was a big challenge, but we also saw a huge opportunity. With data on many more cell lines, we would have far, far greater power to identify functionally important cancer targets."

The latest Project Achilles research also addresses a fundamental question in cancer biology. For decades, cancer has been classified based on tissue of origin, but within the last ten years, many scientists have suggested that it may be more revealing to classify tumors based on genetic mutations, regardless of where the cancer first began.

"Many of us in the genomics field including myself were thinking that maybe someday, we won't care about the organs that cancers come from, that we will only care about the genetic mutations that drive them," said Hahn. "What's emerging from TCGA and our Project Achilles work is that lineage will continue to be important."

Hahn suspects that in some cases, this may have to do with the way that different organ systems develop. One of the top genes that the Project Achilles team detected in ovarian cancer cells is PAX8, which plays an important role in the development of the female reproductive system. They found too many copies of PAX8 in 16 percent of the ovarian cancers they examined. In cell lines where PAX8 was overexpressed, suppressing PAX8 led to cell death.

In addition to their findings in ovarian cancer, the researchers found that looking across cancer types can reveal cancer-causing genes, but only if a large number of samples is considered.

"A traditional way of doing these experiments was to compare one cell line versus another cell line," said Hahn. "When you test that, it turns out that's not a very robust way of doing things. What we show in this paper is that if you have eight or nine cell lines that you're comparing against each other, then your confidence in the candidates that emerge increases."

In the coming months, Hahn and his team plan to pursue the PAX8 result. Although the gene encodes a transcription factor, a class of master control proteins that have been pessimistically labeled "undruggable," the researchers will team up with the Broad's Chemical Biology Platform to look through hundreds of thousands of unique compounds to find one that can neutralize PAX8. "PAX8 is a transcription factor and it's considered a difficult or impossible target to make drugs against, but that's exactly the kind of project that the Broad likes to take on," said Hahn.

Meanwhile, the Hahn lab, RNAi Platform, and other Broad investigators are further pursuing the Project Achilles strategy, screening many more cell lines and devising new analysis methods to nominate promising target genes in many different types of cancer.


'/>"/>

Contact: Nicole Davis
ndavis@broadinstitute.org
617-714-7152
Broad Institute of MIT and Harvard
Source:Eurekalert

Related medicine news :

1. International Diabetes Federation awards $2 million to 9 global diabetes research projects
2. Wingman Project Implemented for Deep Freeze Mission
3. San Diego State University and BIOCOM Institute Receive $4.95 Million Grant: The BRIDGE Project, Linking Education to Employment in San Diegos Life Sciences Industry
4. Partners Home Care Scores in Top Tier in National Medicare Demonstration Project
5. State of Oregon Department of Human Services Selects Netsmart Technologies for Comprehensive Behavioral Healthcare Integration Project
6. Project Runways Tim Gunn Returns to Address Psoriasis(TM) and Empower Patients to be Confident in Their Personal Style
7. Project Prevention Brings Controversial Sterilization Program to Honolulu
8. Good Vibrations Announces New Donation Partner: Global Justice Ecology Project
9. ORNL earns project of year award from tech transfer group
10. China VoIP & Digital Telecom Subsidiary, Beijing PowerUnique Technologies, Wins Virtualization Project Bid for Peking Universitys Third Hospital
11. The NASCAR Foundation Announces The Big Five Projects for NASCAR Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... ... , ... Apple Rehab Shelton Lakes , which specializes in the delivery ... as part of a disaster drill on October 3rd. , Apple Rehab participated with ... Manager, as well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). ...
(Date:10/13/2017)... York, NY (PRWEB) , ... October 13, 2017 , ... ... influential people in business to advocate for action towards gender equality at their inaugural ... views from around the globe, and reached a social audience of over 3 million. ...
(Date:10/13/2017)... ... , ... Talented host, actor Rob Lowe, is introducing a ... episode of "Success Files," which is an award-winning educational program broadcasted on PBS ... in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve in ...
(Date:10/13/2017)... ... 2017 , ... “America On The Brink”: the Christian history of the United ... the creation of published author, William Nowers. Captain Nowers and his wife, Millie, ... spent thirty years in the Navy. Following his career as a naval aviator ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... INDIANAPOLIS , Oct. 2, 2017  Eli Lilly ... its financial results for the third quarter of 2017 ... a conference call on that day with the investment ... performance. The conference call will begin at ... public can access a live webcast of the conference ...
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology: